Skip to main content

副鼻腔拡張デバイス市場 Expected to Reach $5,778 Million by 2023 - Allied Market Research

 Sinus Dilation Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,"the global sinus dilation devices market was valued at $3,326 million in 2016, and is projected to reach $5,778 million at a CAGR of 8.1% from 2017 to 2023.

Sinusitis is a medical condition wherein inflammation of sinus lining leads to a plugged nose, headache, poor sense of smell, sore throat, and cough. It is caused due to either ostial blockage, bacterial infections, viral infections, or a combination of these conditions. This leads to use of sinus dilation devices during surgical procedures to dilate the sinus openings of a patient's nose.


Request for Sample Report at: https://www.alliedmarketresearch.com/request-sample/2128

The major factors that drive the global sinus dilation devices market are increase in incidence of sinusitis, which may lead to higher sinus surgeries, high adoption of minimally invasive surgical procedures, and technological advancements in sinusitis treatment. However, risks associated with sinus surgical procedures and low adoption of surgical procedures, due to presence of alternative sinusitis-related drugs, are expected to restrain the market growth. Conversely, untapped market potential in the emerging countries, such as China and India, and large investments by key players to develop advanced products are expected to provide lucrative opportunities to the market players.

The balloon sinuplasty systems segment accounted for the largest share in 2016, owing to the advancements in sinus surgical procedures, applicability, and their greater acceptance than invasive traditional surgeries. Furthermore, the sinus stents segment is expected to grow at a CAGR of 7.2% from 2017 to 2023, and maintain its dominance in the future as well.

The utilization rate of sinus dilation devices in hospitals & clinics is high; however, the ambulatory surgical centers segment is expected to grow at the highest CAGR. This is attributed to the increasing preference for less hospital stay-associated surgeries with advanced sinus dilation devices.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2128

Key findings of the Sinus Dilation Devices Market: 

  • The balloon sinuplasty system segment accounted for around three-fifths share of the global sinus dilation devices market in 2016.
  • The FESS instruments set segment is expected to grow at a CAGR of 9.3% from 2017 to 2023.
  • The hospitals & clinics segment accounted for around three-fourths share in 2016.
  • Europe accounted for around one-third share of the global sinus dilation devices market in 2016.

North America was the highest revenue contributor to the global sinus dilation devices market in 2016, and is expected to dominate the market during the forecast period as well. This is attributed to the early approval of sinus dilation devices and rapid use of these devices, owing to rise in number of sinus surgical procedures. However, Asia-Pacific is expected to grow at the highest CAGR of 9.6%, owing to increase in affordability, surge in healthcare expenditure, and rise in awareness towards sinusitis-related surgeries.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas. 

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com  

Labels:

Comments

Post a Comment

Popular posts from this blog

放射線情報システム市場 is expected to reach $941 million by 2022, supported by a CAGR of 5.9%

T he radiology information system market was valued at  $603 million  in 2015, and is projected to reach  $941 million  by 2022, growing at a CAGR of 5.9% from 2016 to 2022. The integrated radiology information systems segment held over three-fifths share of the total market in 2015. Radiology information system (RIS) is a computer networked system used to organize and manage the workflow of medical imagery and radiology department, supporting business analysis in a department. RIS is widely used along with picture archiving and communication system (PACS) and vendor neutral archive to manage billing, record keeping, and image archives. The integrated radiology information systems held the largest share in 2015 and is expected to grow at the highest CAGR of 6.0% during the analysis period. This is owing to the surging adoption and demand of integrated healthcare information technology platforms in various healthcare organization for easy operations to curb over expe...
Post a Comment
Read more

2027年までに9億8,330万ドルを獲得する心臓再同期療法市場

As per the report published by Allied Market Research, the   Cardiac Resynchronization Therapy Market   was pegged at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, growing at a CAGR of 4.9% from 2020 to 2027. Download Sample Report at:  https://www.alliedmarketresearch.com/request-sample/10657 Rise in the geriatric population, increase in the prevalence of cardiovascular diseases, and development in healthcare infrastructure have boosted the growth of the U.S. cardiac resynchronization therapy market. Moreover, high-end technological developments in CRT devices supplemented the market growth. However, product recalls in the U.S., cost of CRT devices, and shortage of healthcare professionals hinder the market growth. On the contrary, developing opportunities in the low economic U.S. states would open lucrative opportunities for the market players. Covid-19 scenario- The integration of CRT pacemaker and cardiac resynchronization therapy defibrill...
Post a Comment
Read more

組織工学市場 to Reach $6.81 Billion by 2027: Allied Market Research

As per the report published by Allied Market Research, the global  Tissue Engineering Market  generated $2.37 billion in 2019, and is projected to garner $6.81 billion by 2027, growing at a CAGR of 14.2% from 2020 to 2027. Rise in need for tissue engineering in organ transplantation, surge in prevalence of chronic diseases and trauma emergencies, and advancements in medical equipment technologies drive the growth of the global tissue engineering market. However, high cost associated with tissue engineered products hampers the market growth. On the contrary, untapped opportunities in the developing markets is expected to create lucrative opportunities in the future. Download Detailed COVID-19 Impact Sample Report at:  https://www.alliedmarketresearch.com/request-for-customization/4323?reqfor=covid Covid-19 scenario: Since the Covid-19 outbreak, clinical research in tissue engineering is temporarily suspended and the funds are redirected for clinical trials for the Covid-1...
Post a Comment
Read more